, 1997 Bacteroides fragilis is a Gram negative nonsporulating anaerobic rod bacterium that makes up about 1 to 2% of the normal human colonic microflora. In 1984, Myer et al. reported that some strains of B.
이경원
core
The microbiota-metabolite-immune axis in colorectal cancer: mechanistic insights and emerging clinical applications. [PDF]
Front ImmunolSun B, Wang T.
europepmc +1 more source
Functionally declining microbiota in chronic disease: beyond taxonomic loss. [PDF]
Gut MicrobesKim HS.
europepmc +1 more source
Bacteroides fragilis toxin promotes gall bladder cancer in mice. [PDF]
Nat MicrobiolChen J +10 more
europepmc +1 more source
The Gut Microbiota-Immunity Axis in Colorectal Cancer: Implications for Immunotherapy and Clinical Translation. [PDF]
CellsSiemińska I.
europepmc +1 more source
An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut. [PDF]
CellSpiga L +27 more
europepmc +1 more source
Oxygen-responsive bacterial glycosphingolipid links symbiont fitness and immune development in neonatal host. [PDF]
CellHeo K +5 more
europepmc +1 more source
Transcriptomic Association Between Poliovirus Receptor (PVR/CD155) and Claudin Signaling Pathways in Colorectal Cancer. [PDF]
Cancer Diagn PrognLehrer S, Rheinstein PH.
europepmc +1 more source
The emerging role of CRISPR-Cas systems in helicobacter pylori and the gut microbiota as regulators of gastrointestinal cancer risk. [PDF]
Front ImmunolBhatti M +5 more
europepmc +1 more source
Intratumoral Bacterial Profiles, Bacterial Co-Detection Patterns, and Molecular Alterations in Colorectal Cancer and Colorectal Polyps: A Vietnamese Cohort Study. [PDF]
MicroorganismsGiang VS +8 more
europepmc +1 more source